https://adisinsight.springer.com/trials/700046113?error=cookies_not_supported&code=2052e1e5-81ff-4568-a5c5-36078dbcf973
A Multi-Center, Open-Label Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate)...
This study evaluated the efficacy and tolerability of ingenol mebutate [PEP 005] as a 0.05% gel in patients with actinic keratoses (AK) on non-head locations
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate
Definition of ingenol mebutate - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
definition ofncidrugdictionary
https://adisinsight.springer.com/drugsafety/803183601?error=cookies_not_supported&code=5474c97d-3b8a-4556-bc97-3ec63cbe55fd
Ingenol mebutate - AdisInsight
A 70-year-old man developed impetigo during treatment with ingenol mebutate. He received treatment with ingenol mebutate 0.015% gel for actinic keratosis. After
adisinsight
https://boris-portal.unibe.ch/entities/publication/c2396bde-d200-44aa-9bd8-3508e2c5915a
Ingenol Mebutate for Lentigo Maligna: A Case Report.
BACKGROUND Lentigo maligna (LM) is a melanoma in situ on sun-damaged skin, with a strong predilection to the head and neck area of the elderly. Many...
lentigo malignacasereport